Neurology News

Alteplase did not appear to have reduced treatment effect among patients with acute ischemic stroke with one or more cerebral microbleeds, according to an analysis of a randomized clinical trial published in Neurology.

The American Academy of Neurology has issued ethical guidance on Aduhelm that outlines important points for neurologists to communicate to patients eligible for the treatment.

AI-powered intelligent care coordination company Viz.ai introduced its cerebral aneurysm detection platform at the Society of Vascular and Interventional Neurology annual meeting.

In 2019, more than 67 million adults in the U.S. reported having a disability, a 1% increase since the prevalence was last examined in 2016, according to findings published in JAMA Network Open.

The AMA recently announced that it is strengthening its efforts to increase the rural physician workforce.

The FDA has approved the release of EaseVRx, a prescription-use immersive virtual reality apparatus intended for patients aged 18 years or older who have been diagnosed with chronic lower back pain.

The FDA has granted breakthrough device designation to Blackrock Neurotech for its MoveAgain Brain Computer Interface System, according to a company press release.

Dimethyl fumarate and fingolimod appeared to have no significant difference in relapse rates, and rituximab appeared to have better relapse outcomes than natalizumab in patients with MS, according to results published in JAMA Network Open.

An international panel of clinical experts has developed a blueprint they said contains steps to reduce the millions of “potentially preventable” deaths caused by critical illness annually.

The American Academy of Neurology has issued a guideline providing recommendations for treating motor symptoms in people with early Parkinson’s disease.